Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
It is currently recognized that perpetual cross talk among key players in tumor microenvironment such as cancer cells (CCs), cancer associated fibroblasts (CAFs), and endothelial cells (ECs) plays a critical role in tumor progression, metastasis, and therapy resistance. Disruption of the cross talk may be useful to improve the outcome of therapeutics for which limited options are available. In the current study we investigate the use of gold nanoparticles (AuNPs) as a therapeutic tool to disrupt the multicellular cross talk within the TME cells with an emphasis on inhibiting angiogenesis. We demonstrate here that AuNPs disrupt signal transduction from TME cells (CCs, CAFs, and ECs) to ECs and inhibit angiogenic phenotypes in vitro. We show that conditioned media (CM) from ovarian CCs, CAFs, or ECs themselves induce tube formation and migration of ECs in vitro. Migration of ECs is also induced when ECs are cocultured with CCs, CAFs, or ECs. In contrast, CM from the cells treated with AuNPs or cocultured cells pretreated with AuNPs demonstrate diminished effects on ECs tube formation and migration. Mechanistically, AuNPs deplete ∼95% VEGF165 from VEGF single-protein solution and remove up to ∼45% of VEGF165 from CM, which is reflected on reduced activation of VEGF-Receptor 2 (VEGFR2) as compared to control CM. These results demonstrate that AuNPs inhibit angiogenesis via blockade of VEGF-VEGFR2 signaling from TME cells to endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, gold NPs block VEGF-VEGFR2 signaling from TME cells to endothelial cells and inhibit angiogenesis as reflected in reduced migration and tube formation of ECs when co-cultured with TCs in vitro [52].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Mechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Thus, gold NPs block VEGF-VEGFR2 signaling from TME cells to endothelial cells and inhibit angiogenesis as reflected in reduced migration and tube formation of ECs when co-cultured with TCs in vitro [52] .”
BackgroundGold nanoparticles and gold nanorods in the landscape of cancer therapy
Kesharwani, P., Ma, R., Sang, L., Fatima, M., Sheikh, A., Abourehab, M. A. S., Gupta, N., Chen, Z.-S., & Zhou, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01798-8 · Cited by 337
Hybrid Nanosystems for Biomedical Applications
Seaberg, J., Montazerian, H., Hossen, M. N., Bhattacharya, R., Khademhosseini, A., & Mukherjee, P. (2021) · ACS Nano · doi:10.1021/acsnano.0c09382 · Cited by 198
Self-citationFibroblasts in the Tumor Microenvironment
Truffi, M., Sorrentino, L., & Corsi, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_2 · Cited by 154
Tang, J., Meka, A. K., Theivendran, S., Wang, Y., Yang, Y., Song, H., Fu, J., Ban, W., Gu, Z., Lei, C., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202001469 · Cited by 135
Nanoparticle Interactions with the Tumor Microenvironment
Huai, Y., Hossen, M. N., Wilhelm, S., Bhattacharya, R., & Mukherjee, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00448 · Cited by 113
Self-citationStrategies for Delivering Nanoparticles across Tumor Blood Vessels
Sheth, V. M., Wang, L., Bhattacharya, R., Mukherjee, P., & Wilhelm, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202007363 · Cited by 109
Self-citationThe Application of and Strategy for Gold Nanoparticles in Cancer Immunotherapy
He, J., Liu, S., Zhang, Y., Chu, X., Lin, Z.-B., Zhao, Z., Qiu, S., Guo, Y., Ding, H., Pan, Y., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.687399 · Cited by 82
“Zhang et al. (2019a) investigated the use of AuNPs as a therapeutic tool to disrupt multicellular crosstalk in TME cells, with a focus on inhibiting angiogenesis.”
BackgroundSelf-citationNanotheranostics Targeting the Tumor Microenvironment
Roma‐Rodrigues, C., Pombo, I., Raposo, L. R., Pedrosa, P., Fernandes, A. R., & Baptista, P. V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00197 · Cited by 84
Gold nanoparticles reduce inflammation in cerebral microvessels of mice with sepsis
Di Bella, D., Ferreira, J. P. S., Silva, R. D. N. O., Echem, C., Milan, A., Akamine, E. H., Carvalho, M. H., & Rodrigues, S. F. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00796-6 · Cited by 69
Nano-targeting vascular remodeling in cancer: Recent developments and future directions
Giordo, R., Wehbe, Z., Paliogiannis, P., Eid, A. H., Mangoni, A. A., & Pintus, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.001 · Cited by 73
Self-therapeutic nanomaterials: Applications in biology and medicine
Seaberg, J., Clegg, J. R., Bhattacharya, R., & Mukherjee, P. (2022) · Materials Today · doi:10.1016/j.mattod.2022.11.007 · Cited by 61
Self-citationZhang, Y., Elechalawar, C. K., Hossen, M. N., Francek, E. R., Dey, A., Wilhelm, S., Bhattacharya, R., & Mukherjee, P. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.08.009 · Cited by 55
“Supernatants from untreated or GNP-treated cancer cells, CAFs, or ECs were prepared as described previously [11,13] and illustrated in Fig.”
BackgroundMethodSelf-citationChan, C.-M., Hsiao, C., Li, H., Fang, J., Chang, D., & Hung, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010109 · Cited by 49
Tumor-targeted nano-delivery system of therapeutic RNA
Wang, M., Zhao, J., Jiang, H., & Wang, X. (2022) · Materials Horizons · doi:10.1039/d1mh01969d · Cited by 47
Protein-based delivery systems for RNA delivery
Zhu, H., Luo, H., Chang, R., Yang, Y., Liu, D., Ji, Y. R., Qin, H., Rong, H., & Yin, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.032 · Cited by 40
Recent development and applications of nanomaterials for cancer immunotherapy
Huang, Y., & Zeng, J. (2020) · Nanotechnology Reviews · doi:10.1515/ntrev-2020-0027 · Cited by 36
Tang, J., Meka, A. K., Theivendran, S., Wang, Y., Yang, Y., Song, H., Fu, J., Ban, W., Gu, Z., Lei, C., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202001469 · Cited by 28
Zhao, F., Hu, Z., Li, G., Liu, M., Huang, Q., Ai, K., & Cai, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.04.026 · Cited by 49
“This affects VEGFR binding ability and downstream VEGF/VEGFR2 signaling pathway, which has shown anti-angiogenic effects in cancer and RA [260,261].”
Zhang, Z., Tang, Y., Luo, D., Qiu, J. L., & Chen, L. (2025) · APL Bioengineering · doi:10.1063/5.0244706 · Cited by 26
Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
Zhang, L., Pakmehr, S., Shahhosseini, R., Hariri, M., Fakhrioliaei, A., Shayan, F. K., Xiang, W., & Shayan, S. K. (2023) · Medical Oncology · doi:10.1007/s12032-023-02233-0 · Cited by 30
“Moreover, stromal cells such as ECs [26] and CAFs [27] contribute to immunosuppression though production of vascular endothelial growth factor (VEGF) leads to the formation of aberrant tumor vasculature resulted in hypoxia, thereby impairing the functionality of effector immune cells.”
BackgroundMultifunctional gold nanoparticles for cancer theranostics
Fernandes, D. A. (2024) · 3 Biotech · doi:10.1007/s13205-024-04086-4 · Cited by 25
“…can also be synthesized for use with AuNPs to target important vascular endothelial growth factors (VEGFs) that bind to receptors (i.e., VEGFRs) for blocking signalling pathways associated with angiogenesis (Arvizo et al. 2011; Ferrara and Kerbel 2005; Mukherjee et al. 2005; Zhang et al. 2019).”
The main battlefield of mRNA vaccine – Tumor immune microenvironment
Li, X., Ma, S., Gao, T., Mai, Y., Song, Z., & Yang, J. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109367 · Cited by 23
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment
Essa, N., O’Connell, F., Prina‐Mello, A., O'Sullivan, J. N., & Marcone, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.017 · Cited by 20
Zhang, Y., Elechalawar, C. K., Yang, W., Frickenstein, A. N., Asfa, S., Fung, K.-M. A., Murphy, B., Dwivedi, S. K. D., Rao, G., Dey, A., et al. (2022) · Materials Today · doi:10.1016/j.mattod.2022.01.025 · Cited by 24
Self-citationNavigating Tumor Microenvironment Barriers with Nanotherapeutic Strategies for Targeting Metastasis
Thomas, M. R., Badekila, A. K., Pai, V., Nijil, S., Bhandary, Y. P., Rai, A., & Kini, S. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403107 · Cited by 19
Mapanao, A. K., Sarogni, P., Santi, M., Menicagli, M., Gonnelli, A., Zamborlin, A., Ermini, M. L., & Voliani, V. (2022) · Biomaterials Science · doi:10.1039/d2bm00994c · Cited by 18
Yunna, C., Hu, M., Fengling, W., Wang, L., & Weidong, C. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.05.007 · Cited by 15
Gupta, P. K., Mishra, K., Mittal, A. K., Handa, N., & Paul, M. K. (2023) · Current Nanoscience · doi:10.2174/1573413719666230503144904 · Cited by 17
da Silva, V. D. C. J., da Silva, R. D. N. O., Colli, L. G., de Carvalho, M. H. C., & Rodrigues, S. F. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05591 · Cited by 11
“In fact, VEGF adsorption to gold nanoparticles, even in absence of VEGF neutralizing antibody, was previously reported, in vitro [55].”
BackgroundTargeted therapy of tumour microenvironment by gold nanoparticles as a new therapeutic approach
Mahhengam, N., Kazemnezhad, K., Budi, H. S., Ansari, M. J., Bokov, D. O., Suksatan, W., Thangavelu, L. P., & Siahmansouri, H. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2032095 · Cited by 12
Leveraging Tunable Nanoparticle Surface Functionalization to Alter Cellular Migration
Tetrick, M. G., & Murphy, C. J. (2024) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.3c00055 · Cited by 10
Gold Nanoparticles Affect Pericyte Biology and Capillary Tube Formation
Looprasertkul, S., Sereemaspun, A., Kitkumthorn, N., Sooklert, K., Sarachana, T., & Jindatip, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050738 · Cited by 10
“Moreover, AuNP of this size are frequently applied in HUVEC tube formation and angiogenesis studies [1,17,20,21].”
BackgroundCecchi, D. D., Jackson, N., Beckham, W., & Chithrani, D. B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020175 · Cited by 9
“The targeting of endothelial cells was also achieved by suppressing VEGF-VEGFR2 in ovarian cancer cells, which inhibited angiogenesis [61].”
BackgroundUnlocking the Potential of Gold as Nanomedicine in Cancer Immunotherapy
Kumar, P. P. P., Lee, M., & Kim, T. (2024) · Journal of Nanotheranostics · doi:10.3390/jnt5020003 · Cited by 8
“These These molecules are subsequently recognized by various antigen-presenting cells and tissues, initiating a cascade of immune responses involving DCs and T cells (Figure 6). molecules are subsequently recognized by various antigen-presenting cells and tissues, initiating a cascade of immune…”
BackgroundEl‐Moaty, H. I. A., Ismail, E. H., Abu‐Khudir, R., Soliman, N. A., Sabry, D. Y., Abdulsalam, N. K. A., Sorour, W. A., & Khalil, M. M. H. (2022) · Nanomaterials and Nanotechnology · doi:10.1177/18479804221141266 · Cited by 7
Interrogation of the tumor microenvironment by nanoparticles
Panja, P., Manne, U., Awasthi, V., Bhattacharya, R., & Mukherjee, P. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217454 · Cited by 10
Self-citationStrategies for cancer therapy: targeting tumor microenvironment and nanotechnology
Abdel-Halim, A. H. (2023) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_188_22 · Cited by 6
Tan, Y., Huang, J., Zhang, L., Tang, X., Zhang, C., Xiang, H., Shen, B., Zheng, J., Leng, X., & Li, R. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.111750 · Cited by 6
Cellular microenvironment as an object of targeted therapy for malignant neoplasms
Zyablitskaya, E. Y., Kubyshkin, A. V., Sorokina, L. E., Serebryakova, A. V., Aliev, K. A., Maksimova, P. E., Lazarev, A. E., Balakchina, A. I., & Golovkin, I. O. (2023) · Advances in molecular oncology · doi:10.17650/2313-805x-2023-10-4-8-20 · Cited by 5
Nanoparticles as a Therapeutic Approach for Tumor Angiogenesis
Alghamdi, A. A. A., WalyEldeen, A. A., & Ibrahim, S. (2021) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-8251-0.ch003 · Cited by 4
Nanomodulation and nanotherapeutics of tumor-microenvironment
Dubey, R., Garg, S. S., & Gupta, J. (2022) · OpenNano · doi:10.1016/j.onano.2022.100099 · Cited by 5
pH-Responsive Liposomes for Targeted Detection of Pancreatic Adenocarcinoma Using MSOT
Agarwal, H., Singh, R., Bynum, R. C., McNally, M. W., Chakrabarty, J. H., Jain, A., Grizzle, W. E., & McNally, L. R. (2025) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.5c00034 · Cited by 3
Zhang, S., Li, T., Jiang, D., Shi, H., Hou, H., Fu, Z., & Shi, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1664340 · Cited by 2
Torres-Ortiz, D. A., García‐Alcocer, G., Karla, J.-M., Alicia, D. R.-L., González-Reyna, M. A., & Estevez, M. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae47b3 · Cited by 2
“For instance, biogenic AuNPs created from plant extracts have shown significant anti-cancer properties while retaining biocompatibility in non-cancerous cell lines, underscoring the crucial roles of morphology and synthesis methods in influencing cytotoxic effects [58, 59].”
Kanthireegala, S. K., Lekkala, V. V. V., Lebaka, V. R., Reddy, M. C., Lomada, D., & Mandal, T. K. (2026) · Biomaterials Science · doi:10.1039/d5bm01787d · Cited by 4
Daviu, N., Graciano-Casero, C., & Barber, D. F. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04412-3 · Cited by 3
“Elsewhere, gold-NPs disrupt the communication between tumor and endothelial cells, as the CM of tumor cells induced migration and endothelial tube formation, whereas prior treatment of the endothelial cells with gold-NPs dampened these effects on migration and tube formation [148].”
Targeting Tumor Microenvironment Through Nanotheranostics
Deswal, B., Kapoor, S., & Roy, A. (2021) · Springer eBooks · doi:10.1007/978-981-15-7564-8_7 · Cited by 3
Alex, T. S., Lang, D. K., Zakir, F., Mirza, A., & Iqbal, Z. (2022) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-031-14848-4_1 · Cited by 1
Bella, D. D., Ferreira, J. P. S., Silva, R. D. N. O., Echem, C., Milan, A., Akamine, E. H., de Carvalho, M. H. C., & Rodrigues, S. F. (2021) · Figshare · doi:10.6084/m9.figshare.14067980
Wan, J., Zhou, Y., Zhu, J., Lu, Y., Lyu, Y., Hao, H., Lu, Z., Duckworth, C. A., Liu, Y., Zhou, H., et al. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02810
Jiang, Y., Ding, B., Yin, H., Hua, Y., Ma, N., Hu, P., Deng, J., Wu, F.-G., & Shen, Y. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01845-z · Cited by 1
Metadata
- Authors
- Zhang, Y., Xiong, X., Huai, Y., Dey, A., Hossen, M. N., Roy, R. V., Elechalawar, C. K., Rao, G., Bhattacharya, R., & Mukherjee, P.
- Affiliations
- University of Oklahoma Health Sciences Center (US)
- OU Health Stephenson Cancer Center (US)
- Corresponding author
- Mukherjee, Priyabrata
- ORCID
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-05-08
- Volume
- 30
- Issue
- 6
- Pages
- 1724-1733
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- PMC
- PMC6939887
- OpenAlex
- W2944502936
- Cited by
- 53
- References
- 48
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 9 · 2020: 8 · 2019: 3
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Bioconjugate Chemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA213278, 2CA136494, CA157481, 1R01 CA220237-01A1)
- National Heart, Lung, and Blood Institute (1R01HL120585)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Keywords
- gold nanoparticles, tumor microenvironment, angiogenesis inhibition, endothelial cells, cancer-associated fibroblasts, cancer cells, VEGF165, VEGFR2 signaling, tube formation, endothelial cell migration, conditioned medium, ovarian cancer
- MeSH terms
- Cell Movement, Female, Gold, Humans, Neovascularization, Pathologic, Ovarian Neoplasms, Tumor Cells, Cultured, Signal Transduction, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Endothelial Cells, Metal Nanoparticles, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.